Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular thrombus in a dog by Loewen, Jennifer M. et al.
Veterinary Clinical Sciences Publications Veterinary Clinical Sciences
2018
Concurrent renal amyloidosis and thymoma
resulting in a fatal ventricular thrombus in a dog
Jennifer M. Loewen
Iowa State University
Rachel E. Cianciolo
The Ohio State University
Liwen Zhang
The Ohio State University
Michael Yaeger
Iowa State University, myaeger@iastate.edu
Jessica L. Ward
Iowa State University, jward@iastate.edu
See next page for additional authorsFollow this and additional works at: https://lib.dr.iastate.edu/vcs_pubs
Part of the Small or Companion Animal Medicine Commons, and the Veterinary Pathology and
Pathobiology Commons
The complete bibliographic information for this item can be found at https://lib.dr.iastate.edu/
vcs_pubs/17. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Veterinary Clinical Sciences at Iowa State University Digital Repository. It has been
accepted for inclusion in Veterinary Clinical Sciences Publications by an authorized administrator of Iowa State University Digital Repository. For more
information, please contact digirep@iastate.edu.
Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular
thrombus in a dog
Abstract
Thymoma‐associated nephropathies have been reported in people but not in dogs. In this report, we describe
a dog with thymoma and concurrent renal amyloidosis. A 7‐year‐old castrated male Weimaraner was
presented for progressive anorexia, lethargy, and tachypnea. The dog was diagnosed with azotemia, marked
proteinuria, and a thymoma that was surgically removed. Postoperatively, the dog developed a large left
ventricular thrombus and was euthanized. Necropsy confirmed the presence of a left ventricular thrombus and
histopathology revealed renal amyloidosis. We speculate that the renal amyloidosis occurred secondary to the
thymoma, with amyloidosis in turn leading to nephrotic syndrome, hypercoagulability, and ventricular
thrombosis. This case illustrates the potential for thymoma‐associated nephropathies to occur in dogs and that
dogs suspected to have thymoma should have a urinalysis and urine protein creatinine ratio performed as part
of the pre‐surgical database.
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Thymoma-associated nephropathies have been reported in people but not in dogs. In this report,
we describe a dog with thymoma and concurrent renal amyloidosis. A 7-year-old castrated male
Weimaraner was presented for progressive anorexia, lethargy, and tachypnea. The dog was diag-
nosed with azotemia, marked proteinuria, and a thymoma that was surgically removed.
Postoperatively, the dog developed a large left ventricular thrombus and was euthanized.
Necropsy confirmed the presence of a left ventricular thrombus and histopathology revealed renal
amyloidosis. We speculate that the renal amyloidosis occurred secondary to the thymoma, with
amyloidosis in turn leading to nephrotic syndrome, hypercoagulability, and ventricular thrombosis.
This case illustrates the potential for thymoma-associated nephropathies to occur in dogs and that
dogs suspected to have thymoma should have a urinalysis and urine protein creatinine ratio per-
formed as part of the pre-surgical database.
K E YWORD S
hypercoagulability, nephrotic syndrome, paraneoplastic, protein losing nephropathy
1 | INTRODUCTION
A 7-year-old castrated male Weimaraner was presented for a 4-day
history of progressive anorexia, lethargy, fever, tachypnea, vomiting,
and soft feces. On physical examination, the dog was mildly hyperther-
mic (102.68F), dehydrated (5%), tachycardic (150 bpm), and tachypneic
(66 bpm) with a restrictive breathing pattern. Heart and lung sounds
were decreased, and the dog was painful on abdominal palpation.
Hematologic abnormalities included: leukocytosis (26 080 white blood
cells [WBC]/mL; reference interval [RI], 6000–17 000 WBC/mL) charac-
terized by a neutrophilia (18 780 cells/mL; [RI], 3000–11 400 cells/mL)
and monocytosis (3130 cells/mL ; [RI], 150–1350 cells/mL). Biochemical
abnormalities included azotemia (BUN 57 mg/dL; [RI], 10–30 mg/dL;
creatinine 3.7 mg/dL; [RI], 0.5–1.5 mg/dL; hyperphosphatemia 8.9 mg/
dL; [RI], 3.2–6.0 mg/dL), decreased bicarbonate (16.0 mEq/L; [RI], 19–
25 mEq/L), hypoalbuminemia (2.1 g/dL; [RI], 2.7–4.0 g/dL), hypercho-
lesterolemia (436 mg/dL; [RI], 132–300 mg/dL), hyperbilirubinemia
(0.66 mg/dL; [RI], <0.1–0.6 mg/dL), mildly increased ALP (192 U/L;
[RI], 20–150 U/L), and mild electrolyte alterations (sodium 135 mEq/L;
Abbreviations: AA, amyloid A; PLN, protein losing nephropathy; TEG,
thromboelastography; UPC, urine protein to creatinine; WBC, white blood cell.
Work performance sites: Clinical case was from Iowa State University (ISU).
This case report has not been reported elsewhere.
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[RI], 141–151 mEq/L; chloride 108 mEq/L; [RI], 112–121 mEq/L; cal-
cium 8.9 mg/dL; [RI], 9.7–11.3 mg/dL). Other than moderate hypocal-
cemia abnormalities were not detected on a chemistry panel
performed 2 days prior to presentation (BUN 16 mg/dL; [RI], 7–27;
creatinine 1 mg/dL; [RI], 0.5–1.8; albumin 2.9 g/dL; [RI], 2.3–4). A urine
sample collected after 16 hours of fluid therapy had a specific gravity
of 1.013 and 31 proteinuria with inactive sediment. Urine culture was
negative. A urine protein to creatinine (UPC) ratio was markedly
increased at 15.5. Prothrombin and partial thromboplastin times were
mildly prolonged (PT 8.1 seconds; [RI], 5.5–7.9 seconds; PTT 19.8 sec-
onds; [RI], 10.4–19.3 seconds). Thoracic radiographs showed border
effacement of the cardiac silhouette and dorsal displacement of the
thoracic structures suggestive of a thoracic mass or pleural effusion.
Pleural fluid was confirmed with a cage side ultrasound and a thoraco-
centesis was performed to sample the fluid. Analysis of the pleural fluid
was consistent with an exudate: 21 500 cells/mL, total protein of 2.6 g/
dL, with moderate, mixed leukocytic (predominantly neutrophilic)
inflammation and large atypical mononuclear cells suspected to be
reactive mesothelial cells.
Thoracic ultrasound demonstrated a large, solid, mildly heteroge-
neous cranial mediastinal mass measuring at least 9.7 3 10 cm. An
ultrasound-guided fine needle aspirate was performed and cytology of
the mass showed a small, mature lymphoid cell population with mild
neutrophilic inflammation and abundant necrosis, suggestive of a thy-
moma or thymic lymphoma. Because treatment modalities differ for
thymoma and lymphoma, an abdominal ultrasound was performed to
look for evidence of multicentric lymphoma. The ultrasound revealed
mild hepatomegaly and a prominent muscularis layer of the gastric fun-
dus. Liver fine needle aspirates suggested mild cholestasis with no evi-
dence of lymphoma. Leptospira titers were all 1 : 400, consistent
with vaccination performed 2.5 weeks ago. A reassessment of the
dog’s biochemical variables on day 5 showed progressive azotemia
(BUN 117 mg/dL, creatinine 6.5 mg/dL, phosphorous 13.1 mg/dL), pro-
gressive hypoalbuminemia (2.0 g/dL), persistent ALP increase (ALP 188
U/L) and progressive ALT increase (ALT 192 U/L; [RI], 24–90 U/L), and
hyperbilirubinemia (0.75 mg/dL).
In an attempt to differentiate between thymoma and thymic lym-
phoma, ultrasound-guided Tru-Cut biopsies of the mass were per-
formed. On histopathology, the mass demonstrated diffuse necrosis
with some lymphocytes. The presence of lymphocytes combined with
the mass location made thymoma or thymic lymphoma likely diagnoses.
However, a conclusive diagnosis could not be made due to the necro-
sis. Bacterial culture of a biopsy specimen yielded no growth.
Varying arrhythmias were noted throughout hospitalization. The
dog’s underlying rhythm was normal sinus rhythm with right bundle
branch block and a short PR interval suggestive of ventricular pre-
excitation through an accessory pathway. During anesthetic induction,
this rhythm was initially misinterpreted as an accelerated idioventricular
rhythm and treated with lidocaine. While recovering postoperatively,
the dog experienced intermittent paroxysms of narrow-complex tachy-
cardia suspected to be supraventricular tachycardia conducted through
the atrioventricular node. Occasional ventricular premature complexes
of varying morphology were also noted. Various treatments were
instituted for the tachycardia including diltiazem, procainamide, esmo-
lol, and lidocaine with variable response to procainamide and diltiazem
in restoring a normal rate. An echocardiogram was performed to assess
the dog’s heart given the frequent bouts of supraventricular tachycar-
dia. The study was difficult due to the mass compressing the heart,
however, there was subjectively decreased systolic function and ques-
tionable spontaneous contrast seen in the left ventricle, suggestive of
vascular stasis.
On the evening of day 6, the dog started to develop noticeable
facial edema suspected to be due to the mass compressing the vena
cava. Because previous less invasive methods were unsuccessful in
obtaining a definitive diagnosis, the dog’s owner elected to pursue
removal of the cranial mediastinal mass. Presurgical serum biochemical
analysis on day 6 showed a static azotemia and a mild increase in liver
enzymes compared to the previous day. Presurgical coagulation panel
revealed normal PT and aPTT with increased D-dimers (1081 ng/mL;
[RI], 0–400 ng/mL).
On day 7, a median sternotomy was performed and a 0.7 kg, 7.6 3
15.2 cm mass was removed from the dog’s cranial mediastinum.
A thoracostomy tube and esophagostomy tube were placed at the time
of surgery.
After surgery, the dog was supported with fluid therapy (intravenous
administration of hypotonic and isotonic crystalloids), esophagostomy
tube feedings, a continuous rate infusion of fentanyl, gastroprotectants
(sucralfate, omeprazole), metoclopramide, and broad spectrum antibi-
otics (ampicillin and metronidazole). Benazepril (0.5 mg/kg q24h) and
clopidogrel (2 mg/kg PO q24h) were commenced to address the pro-
teinuria and associated thrombotic risk, respectively. Urine production
was closely monitored with an indwelling urinary catheter and
remained above 1 mL/kg/h. The azotemia remained relatively static
(day 8 creatinine: 6.9 mg/dL; day 10 creatinine: 6.3 mg/dL). The
facial edema originally improved, however, on the evening of day 9 (2
days after surgery) it returned and continued to progress. Due to sus-
picion of a thrombus, D-dimers were reassessed and had decreased
(796 ng/mL).
At this time, given the dog’s progressive facial edema and recurrent
tachycardia, a thoracic ultrasound was performed to look for potential
thrombi in the great vessels that could be contributing to the facial
edema and any cardiac abnormalities that could be predisposing him
to arrhythmias. A large thrombus was present in the left ventricle
(Figure 1); no thrombi were visualized in the great vessels. Abdominal
ultrasound performed at the same time showed several new renal
infarcts. At this time, given the guarded prognosis, euthanasia was
elected and an necropsy was performed.
Histopathology of the thoracic mass removed at surgery showed
marked necrosis and moderate numbers of neutrophils with coalescing
aggregates of small lymphocytes admixed with larger, round to polygonal
epithelioid cells which formed rare aggregates. Immunohistochemistry
demonstrated both cytokeratin and CD3 immunoreactive cells support-
ing a diagnosis of thymoma. The mass was also surrounded by a thick
fibrous capsule with areas of hemorrhage, fibroplasia (internally), and foci
of lymphocytes, plasma cells, and macrophages. There was no evidence
of amyloid deposition in the thymoma based on Congo red staining.
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On necropsy, there was a 6 3 4 3 4 cm thrombus within the left
ventricular lumen extending through the mitral valve into the left
atrium (Figure 1). The left ventricular free wall had multiple myocardial
infarcts with numerous intra-arterial fibrin thrombi. Thrombi were also
present in pulmonary, splenic, and renal arteries. Mild, acute, focal sup-
purative and hemorrhagic pancreatitis was present likely explaining the
dog’s hepatic enzyme abnormalities. Moderate centrilobular and midzo-
nal hepatic congestion was also present, but no hepatic thrombi were
noted. The subcutis of the entire ventrum (abdomen, chest, neck, head)
was moderately to markedly expanded by clear, glistening fluid repre-
senting edema. Histopathology of kidney samples submitted to the
International Veterinary Renal Pathology Service revealed severe
expansion of the mesangium and capillary walls by waxy eosinophilic
material consistent with amyloid. The Congo red method demonstrated
apple-green birefringence of the material when examined with polar-
ized light. Similar congophilic material was also identified in arterial
walls and the medullary interstitium (Figure 2). Moderate to focally
severe chronic interstitial fibrosis and tubular atrophy was also present.
Transmission electron microscopy revealed abundant, haphazardly
arranged non-branching fibrils with a cross-sectional diameter of 11 to
16 nm. There was no ultrastructural evidence of immune-complex
deposits.
Proteins were extracted from formalin-fixed, paraffin embedded
kidney tissue and digested with trypsin overnight. The digests were
analyzed by nano liquid chromatography tandem mass spectrometry on
an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific,
Waltham, Massachusetts) for protein identification. Data were
searched on MASCOT (MatrixScience, Boston, Massachusetts) against
the Swiss-Prot other mammal database which contains protein sequen-
ces of mammals other than primates and rodents. Search results
showed a total of 8 unique peptides were detected for Serum Amyloid
A (AA; well beyond the requirement of at least 2 unique peptides per
protein for protein identification). The detected peptide sequences rep-
resented 45% of the protein sequence, suggesting serum AA was iden-
tified confidently in the kidney tissue.
2 | DISCUSSION
This report describes a Weimaraner with thymoma, renal amyloidosis,
severe protein losing nephropathy, a large ventricular thrombus, and
evidence of thromboembolic disease. Although relatively uncommon in
dogs, thymomas are one of the most common cranial mediastinal
tumors in dogs.1 Thymomas are neoplasms of the thymic epithelium
that tend to develop in older medium to large breed dogs.1 Clinical
signs are usually nonspecific relating to chronic illness such as weak-
ness or lethargy, cough related to the mediastinal mass, or a manifesta-
tion of a paraneoplastic syndrome such as myasthenia gravis and
megaesophagus,1,2 hypercalcemia,3 severe lymphocytosis,4 erythema
multiforme,5 and myocarditis.3 A large percentage of dogs (20%-40%)
with thymomas have concurrent nonthymic neoplasms or immune-
mediated disease.1,3,4 Thymoma-associated nephropathies have been
reported in up to 1%-2% of human patients and include glomerulo-
nephritis or nephrotic syndrome.6,14
Amyloidosis is characterized by the extracellular deposition of
insoluble, haphazardly arranged fibrillary proteins with a characteristic
beta-sheet conformation at the molecular level.7,8 Amyloid deposition
can be generalized or organ-specific. It is an uncommon disorder in
dogs, but the kidney is the most common site of amyloid deposition.9
Proteinuria, with or without nephrotic syndrome, is the most common
sequela of renal amyloidosis in humans and dogs.7,8 In human patients,
renal amyloidosis is characterized by the type of protein that makes
the amyloid fibrils and include serum AA, light chain amyloid, and
hereditary dysproteinemias.7 AA amyloidosis is associated with chronic
inflammatory processes (such as arthritis, infection, familial Mediterra-
nean fever) and neoplasms that lead to increased serum AA production.
Light chain amyloidosis results from plasma cell dyscrasias or lympho-
mas that produce amyloidogenic light chains.7,10 In hereditary amyloi-
dosis, a genetic mutation leads to generation of an amyloidogenic
protein. Familial amyloidosis in the Chinese Shar-Pei and Abyssinian cat
are due to serum AA but there might be a familial predisposition for
increased synthesis.8 Interestingly, intratumoral amyloid production by
FIGURE 1 A, Ultrasonographic cross-sectional image of the left
ventricle demonstrating a large thrombus within the ventricle
lumen denoted by the arrow. B, Necropsy images showing the
heart cut sagitally displaying the large thrombus in the left
ventricle, extending into the left atrium
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thymomas has been reported in a woman and several cats.11,12 Thus,
we explored the possibility that the source of the renal amyloid in this
dog could have been the thymoma itself. However, this dog’s thymoma
was negative for amyloid.
Renal amyloidosis in non-Shar-Pei dogs occurs in middle aged to
older dogs with common presentations similar to that of the dog in this
report of anorexia, vomiting, and lethargy.8,9 A history of comorbid dis-
ease, such as neoplasia or inflammation, is commonly present in dogs
with renal amyloidosis.8 It is likely these patients also have another pre-
disposing factor, such as decreased ability to clear amyloid, as second-
ary amyloidosis is rare in patients with chronic inflammatory disease.9
As seen in this dog, leukocytosis and hypoalbuminemia are the most
common hematologic and biochemical abnormalities described in dogs
with renal amyloidosis.8 Dogs with renal amyloidosis also commonly
demonstrate azotemia, hypercholesterolemia, isosthenuria, and a
UPC>2.8 We believe this dog developed renal amyloidosis in conjunc-
tion with the thymoma. Unfortunately, there was no urinalysis per-
formed before this illness, so we cannot confirm the proteinuria was
new. However, the severity of the proteinuria, the new and rapidly pro-
gressive azotemia while in hospital, and the dramatic thrombotic seque-
lae support a recent decompensation. Furthermore, reported median
survival times in dogs with renal amyloidosis is only 5 days.8
Mass spectrometry confirmed that this dog’s amyloidosis was AA.
While AA renal amyloidosis has been reported to develop secondary to
many chronic inflammatory and neoplastic diseases in people and dogs,
it has not been reported secondary to thymoma in either species. In
this case, the thymoma had regions of tumoral inflammation, necrosis,
and inflammation of its fibrous capsule, all of which may have led to
serum AA generation and subsequent amyloidosis as seen with other
cases of tumors with inflammation.13 Several other paraneoplastic glo-
mulerulopathies have also been reported secondary to thymoma in
humans including minimal change disease, membranous nephropathy,
focal segmental glomerulosclerosis, rapidly progressive glomeruloneph-
ritis, and lupus nephritis.6,14 Autoreactive T cell clones escaping nega-
tive selection in the abnormal thymic tissue or suppression of
regulatory T-cells controlling self-tolerance are likely integral in devel-
opment of thymoma-associated autoimmune disease and may have
contributed to serum AA production in this case.6,15 Minimal change
disease, a glomerulopathy associated with nephrotic syndrome, was
described in an older woman with recurrent thymoma.16 Interestingly,
when her thymoma was treated and her proteinuria decreased, her
Th17/regulatory T cell ratio decreased.16 We propose that a combina-
tion of thymoma associated and immune dysregulation and tumoral
inflammation may have resulted in renal amyloid deposition in this dog.
FIGURE 2 A, Photomicrograph of a glomerulus in a dog with glomerular amyloidosis and concurrent thymoma. There is segmental
expansion of the glomerular tuft by extracellular eosinophilic matrix which compresses the capillary lumens (HE stain, Bar550 lm). B, Same
glomerulus stained with Masson’s Trichrome reveals the material is pale blue and waxy. There is mild diffuse interstitial fibrosis (Masson’s
Trichrome, Bar550 lm). C, Glomerulus stained with Congo red demonstrating prominent peach staining of the glomerular mesangium. This
material demonstrated faint apple-green birefringence when viewed with polarized light (Congo red method, Bar550 lm). D, Same
glomerulus as A and B stained with Jones methenamine silver (JMS) reveals that the extracellular material is not argyrophilic (JMS method,
Bar550 lm)
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This dog was euthanized due the presence of a large ventricular
thrombus, which likely occurred as a complication of nephrotic syn-
drome. This dog demonstrated all components of the tetrad of
nephrotic syndrome including proteinuria, hypoalbuminemia, peripheral
edema, and hypercholesterolemia. Nephrotic syndrome is reported in
10% of non-Shar-Pei dogs with renal amyloidosis8 and 24% of human
patients with renal amyloidosis.7 Nephrotic syndrome has been asso-
ciated with hypercoagulable states and a predisposition for thrombosis
in dogs and humans.17–19 In our dog, renal amyloidosis and protein los-
ing nephropathy (PLN) may have led to a hypercoagulable state and
thrombosis. Thromboemboli were found in up to 38% of dogs with
renal amyloidosis with both arterial and venous locations with pulmo-
nary arterial thrombi being the most common.8,20 The incidence of
thromboembolic complications in people with nephrotic syndrome has
been reported as high as 44%21,22 and a recent thromboelastography
(TEG) study in dogs with PLN found 89% of dogs were hypercoagulable
by TEG analysis.23 Dogs with nephrotic syndrome are thought to be
hypercoagulable due to urinary loss of antithrombin, hyperfibrinogene-
mia as a result of ongoing inflammation, and platelet hyperaggregability
secondary to hypoalbuminemia.24 High molecular weight clotting fac-
tors such as factor V and VIII are also increased in humans with PLN,
likely due to increased synthesis disproportionate to urinary loss.22
Hypovolemia leading to vascular stasis may also be a predisposing fac-
tor to thromboembolism in some PLN patients.25 In most dogs with
PLN, the UPC ratio, serum albumin concentration, and plasma antith-
rombin activity are not predictive of thromboembolic complications and
do not predict TEG-based hypercoagulability.19,23,25 The lack of ability
to identify one marker that predicts hypercoagulablity in dogs with PLN
suggests the predisposition is multifactorial. Unfortunately, in this dog,
antithrombotic therapy was not commenced until day 8 of hospitaliza-
tion because of the planned thoracotomy and a desire to avoid exces-
sive surgical hemorrhage. It is unclear if more aggressive prophylactic
therapy could have prevented this dog’s thromboembolic disease.
One striking feature in this dog was the ventral edema and marked
facial edema. This edema was likely a sequelae of nephrotic syndrome,
because the cardiac thrombus was both left-sided and ventricular (as
opposed to right atrial) and thus should not have caused increased
hydrostatic pressure in the vena cavae or systemic veins. However,
other factors may have contributed such as disrupted lymphatic drain-
age postoperatively.
The treatment of choice for thymomas in dogs is surgical resection
and surgery is typically associated with prolonged survival (median 635
days).1 In a recent large cases series of dogs with thymoma, presence
of paraneoplastic syndromes such as myasthenia gravis did not impact
postoperative survival times.1 Unfortunately, this dog’s proteinuria and
thrombotic complications made his prognosis grave.
Findings in this dog suggest thymoma-associated nephropathies
may occur in dogs as well as humans. We hypothesize this dog devel-
oped renal amyloidosis secondary to his thymoma. We propose that
renal amyloidosis resulted in proteinuria, development of a hyper-
coagulable state, and ultimately dramatic thromboembolic sequelae.
No studies are available in canine medicine to document renal pathol-
ogy in conjunction with thymomas. Additional research is needed to
definitively confirm the link between thymoma and amyloidosis or
other renal pathologies in dogs and to elucidate the pathogenesis of
this relationship. In dogs with thymoma, UPC ratios should be moni-
tored closely and renal biopsies may be warranted at the time of thy-
moma surgery if proteinuria is present. Similarly, dogs with glomerular
disease should be screened for underlying malignancy as recognition of
paraneoplastic glomerular disease could be life-saving.
In summary, we describe a dog with thymoma and concurrent
renal AA amyloidosis. This case demonstrates the possible mechanisms
by which a thymoma could lead to systemic reactive amyloidosis-
tumoral inflammation coupled with immune dysregulation. This case
also highlights the importance of screening all animals with thymoma
for proteinuria. Secondary to the renal amyloidosis, the dog developed
devastating sequelae of nephrotic syndrome, namely an intraventricular
thrombus. Unfortunately, given the dog’s need for surgical intervention,
antithrombotic therapy for his suspected hypercoagulable state was
delayed and the dog succumbed to thrombotic complications. How-
ever, early and aggressive antithrombotic therapies should be imple-
mented in dogs with nephrotic syndrome whenever possible.
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